Table 2

LIVE Score validation cohort—Kaiser Permanente mortality and healthcare utilisation

Variables in 2013Overall
n=17 124
LIVE 1
n=264
LIVE 2
n=667
LIVE 3
n=3472
LIVE 4
n=6443
LIVE 5
n=6278
P value
N (%)17 124 (100)264 (0.02)667 (0.04)3472 (20)6443 (38)6278 (37)<0.001
4 year mortality3206 (18.7)167 (63.3)316 (47.4)1353 (39.0)1098 (17.0)272 (4.3)<0.001
Transthoracic echocardiogram3006 (17.6)133 (50.4)318 (47.7)1140 (32.8)958 (14.9)457 (7.3)<0.001
Chest CT2548 (14.9)78 (29.5)281 (42.1)778 (22.4)938 (14.6)473 (7.5)<0.001
ED COPD visits0.49±1.00.89±1.30.98±1.90.74±1.20.48±1.00.21±0.6<0.001
Inpatient COPD visit0.47±0.91.33±1.11.42±1.50.81±1.00.37±0.70.10±0.4<0.001
OP COPD visit2.11±3.01.50±2.91.99±3.72.45±3.92.31±3.01.70±2.2<0.001
OP any visit18.66±21.526.89±31.530.67±31.526.65±30.218.53±18.112.74±13.4<0.001
Inpatient any visit0.57±1.22.34±2.02.39±2.01.10±1.40.45±0.90.13±0.5<0.001
ED any visit1.24±2.23.46±3.53.58±3.71.86±2.51.19±2.10.60±1.5<0.001
  • A table summarising the healthcare utilisation for the 17 124 patients is shown. Healthcare utilisation measured by ED visits and inpatient visits for COPD and any cause followed a similar pattern as mortality. The highest-risk patients (LIVE 1 and 2) had the highest rate of ED visits and hospitalisations for COPD and any cause, while the lowest-risk patients (LIVE 5) had the lowest rate. Analysis of variance was used to determine statistical significance for continuous variables (COPD visits) and Fisher’s exact test was used to determine statistical significance for categorical variables (mortality, transthoracic echocardiogram and chest CT). Analysis of variance was used to determine statistical significance for continuous variables (COPD visits) and Fisher’s exact test was used to determine statistical significance for categorical variables (mortality, transthoracic echocardiogram and chest CT)

  • COPD, chronic obstructive pulmonary disease; ED, emergency department; LIVE, Laboratory-based Intermountain Validated Exacerbation; OP, outpatient.